Market Cap
₩1.091 Trillion
KRW as of Jan. 1, 2026
US$756.4 Million
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
UnitedHealth Group
|
$304.72 B |
South Korea
languages
Healthcare
languages
Drug Manufacturers—Specialty & Generic
South Korea Healthcare
South Korea Drug Manufacturers—Specialty & Generic
Chong Kun Dang Pharmaceutical Corp has the following listings and related stock indices.
Stock: KRX: 185750
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.